Molecular Testing for Mycoplasma spp., Ureaplasma spp., Chlamydia trachomatis
Scientific studies have demonstrated that infertile women exhibit significantly higher infection rates of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum compared to women without reproductive health issues.
These pathogens are associated with chronic inflammation of the reproductive tract, which can negatively impact fertility. Molecular diagnostic testing offers a highly sensitive and specific method for detecting these microorganisms, facilitating early diagnosis and appropriate treatment to improve reproductive outcomes.
Sample Type: Cervical or urethral smear
Turnaround Time: 1 week